NextMed Founded: 2020 Total raised: Undisclosed What NextMed does: NextMed began as a COVID-19 testing startup but moved into prescribing GLP-1s for weight loss in July 2022
(~0.7-1.0 gm of protein per pound of body weight)
Supports Healthy Satiety & Craving Control: Featuring Berberine HCL and L-Glutamine, this GLP-1 support complex helps manage food cravings and promotes natural feelings of fullness (satiety), making healthy portion management easier and supporting metabolic wellness
Attempting to stretch doses beyond this window increases risk without adding benefit
The Onyx Med Spa 115 Farley Cir #202 Lewisburg, PA 17837 Hours of Operation Tues - Fri: 8am - 6pm Saturday & Sunday: Appt
If the drugs are directly both improving weight reduction and cancer reduction, then we need to double down. Ganta wonders the same thing about the drugs apparent positive effects on several conditions, from dementia to sleep apnea: Is it that obesity is causing or contributing to the problem [and that weight loss is causing the improvement], or is the medication directly having an impact through a different mechanism? She hopes there will be more research to parse this out in the years to come